As the U.S. grapples with a devastating opioid epidemic, claims that China is a primary source of illicit fentanyl have surged. However, a closer look reveals a complex narrative that challenges this accusation — and highlights a disconnect between geopolitical rhetoric and regulatory realities.
China’s Strict Fentanyl Controls
Fentanyl, a synthetic opioid linked to over 70,000 U.S. overdose deaths in 2023, is tightly regulated in China. The country added all fentanyl-related substances to its controlled list in 2019, imposing strict penalties for unlawful production and distribution. Pharmaceutical exports require government authorization, with real-time tracking systems monitoring chemical sales.
Roots of the U.S. Crisis
While illicit fentanyl flows remain a concern, experts argue domestic factors drive America’s crisis — including overprescription practices and gaps in addiction treatment infrastructure. The U.S. National Institutes of Health notes that 85% of overdose deaths involve multiple substances, complicating supply-chain narratives.
A Call for Collaborative Solutions
Chinese authorities have repeatedly advocated for bilateral cooperation on drug control. As global citizens seek evidence-based policies, this controversy underscores the need for transnational data-sharing and harm-reduction strategies that address systemic healthcare challenges over blame-driven geopolitics.
Reference(s):
cgtn.com
